Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener Medizinische Wochenschrift
Erschienen in:

22.10.2018 | case report

Acute edema induced by toluidine blue extravasation—first report

verfasst von: Prof. Dr. Uwe Wollina, Dr. André Koch, Birgit Heinig

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 1-2/2019

Einloggen, um Zugang zu erhalten

Summary

Methemoglobinemia is characterized by an increased level of methemoglobin (MetHb) in the peripheral blood. MetHb levels increase after tumescent anesthesia and need to be monitored. If a patient becomes symptomatic and/or the MetHb levels increase >10%, intravenous injection of an antidote is recommended. Toluidine blue is twice as effective as methylene blue in this respect.
A 27-year-old woman with advanced lipedema underwent her third liposuction under tumescent anesthesia. After surgery, her MetHb levels increased and needed injection of toluidine blue. She developed an acute and painful edema after extravasation of some toluidine blue due to a bursting vein. This is the first report in the recent medical literature. Clinical presentation, course, and treatment are described.
Vorheriger Artikel Neurological complications of systemic tumor therapy
Literatur
1.
Skold A, Cosco DL, Klein R. Methemoglobinemia: pathogenesis, diagnosis, and management. South Med J. 2011;104:757–61.CrossRef
2.
Barash M, Reich KA, Rademaker D. Lidocaine-induced methemoglobinemia: a clinical reminder. J Am Osteopath Assoc. 2015;115:94–8.PubMed
3.
Erkuran MK, Duran A, Kurt BB, Ocak T. Methemoglobinemia after local anesthesia with prilocaine: a case report. Am J Emerg Med. 2015;33:602.CrossRef
4.
Fisher J, Taori G, Braitberg G, Graudins A. Methylene blue used in the treatment of refractory shock resulting from drug poisoning. Clin Toxicol (Phila). 2014;52:63–5.CrossRef
5.
Pasin L, Umbrello M, Greco T, Zambon M, Pappalardo F, Crivellari M, Borghi G, Morelli A, Zangrillo A, Landoni G. Methylene blue as a vasopressor: a meta-analysis of randomised trials. Crit Care Resusc. 2013;15:42–8.PubMed
6.
Jang DH, Nelson LS, Hoffman RS. Methylene blue in the treatment of refractory shock from an amlodipine overdose. Ann Emerg Med. 2011;58:565–7.CrossRef
7.
Kiese M, Lörcher W, Weger N, Zierer A. Comparative studies on the effects of toluidine blue and methylene blue on the reduction of ferrihaemoglobin in man and dog. Eur J Clin Pharmacol. 1972;4:115–8.CrossRef
8.
Wollina U. Lipedema: up-to-date of a long forgotten disease. Wien Med Wochenschr. 2017;167(13–14):343–8.CrossRef
9.
Reich-Schupke S, Schmeller W, Brauer WJ, Cornely ME, Faerber G, Ludwig M, Lulay G, Miller A, Rapprich S, Richter DF, Schacht V, Schrader K, Stücker M, Ure C. S1 guidelines: Lipedema. J Dtsch Dermatol Ges. 2017;15:758–67.PubMed
10.
Klein JA. The tumescent technique. Anesthesia and modified liposuction technique. Dermatol Clin. 1990;8(3):425–37.CrossRef
11.
Rapprich S, Koller J, Sattler G, Wörle B, Sommer B, Bechara FG, Koenen W, Kunte C, Grablowitz D, Hoffmann K, Fratila A, Bruning G, Podda M, Schuller-Petrovic S, Karsai S, Schmeller W, Meier-Vollrath I, Faulhaber J, Brodersen J, Boehler K, Löser C. Liposuction—a surgical procedure in dermatology. J Dtsch Dermatol Ges. 2012;10:111–3.PubMed
12.
Augustin M, Maier K, Sommer B, Sattler G, Herberger K. Double-blind, randomized, intraindividual comparison study of the efficacy of prilocaine and lidocaine in tumescent local anesthesia. Dermatology. 2010;221:248–52.CrossRef
13.
Ruhlen JL. Tissue necrosis. Cutaneous and subcutaneous damage following extravasation of methylene blue. J Kans Med Soc. 1982;83(260):236.PubMed
14.
Bleicher RJ, Kloth DD, Robinson D, Axelrod P. Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy. J Surg Oncol. 2009;99:356–60.CrossRef
15.
Khokhar RS, Aqil M, Al-Zahrani T, Gelidan A, Al Khayal K. Novel management of methylene blue extravasation: A case report and review of literature. Saudi J Anaesth. 2015;9:211–3.CrossRef
Metadaten
Titel
Acute edema induced by toluidine blue extravasation—first report
verfasst von
Prof. Dr. Uwe Wollina
Dr. André Koch
Birgit Heinig
Publikationsdatum
22.10.2018
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 1-2/2019
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-018-0666-7

Weitere Artikel der Ausgabe 1-2/2019

Neurological complications of systemic tumor therapy

  • original article

Die Rolle der molekularen Bildgebung (PET-CT) in der Diagnostik und Therapie des Prostatakarzinoms

  • themenschwerpunkt

Nuklearmedizin – Rising or falling star?

  • editorial

68Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?

  • main topic

Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease

  • Open Access
  • main topic

Darstellung und Lokalisation von Nebenschilddrüsenadenomen mit F‑18 Cholin PET/CT

  • Open Access
  • themenschwerpunkt